<div align="center">

# üíº Lilo Engine ‚Äî Investor Overview

### AI-Powered Mental Health Support for Assisted Living

**Transforming elderly mental health care with evidence-based AI therapy**

---

![Version](https://img.shields.io/badge/Version-6.0-blue?style=flat-square)
![Stage](https://img.shields.io/badge/Stage-Production%20Ready-brightgreen?style=flat-square)
![Compliance](https://img.shields.io/badge/HIPAA-Compliant-success?style=flat-square)
![Funding](https://img.shields.io/badge/Built_With-Founder's_Capital-orange?style=flat-square)

</div>

---

## üåç Total Addressable Market: $3+ Trillion Opportunity

<div align="center">

### Global Healthcare Ecosystem

</div>

<table>
<tr>
<td align="center" width="25%">
<h2>$11T</h2>
<sub>Global Healthcare</sub><br/>
<sup>Market (2024)</sup>
</td>
<td align="center" width="25%">
<h2>$1T+</h2>
<sub>Annual Cost</sub><br/>
<sup>Depression & Anxiety</sup>
</td>
<td align="center" width="25%">
<h2>$868B</h2>
<sub>Elder Care Services</sub><br/>
<sup>& Assistive Devices</sup>
</td>
<td align="center" width="25%">
<h2>$450B</h2>
<sub>Mental Health</sub><br/>
<sup>Market (2024)</sup>
</td>
</tr>
</table>

### Market Opportunity Landscape

```mermaid
flowchart TD
    subgraph TAM["$3+ Trillion Total Addressable Market"]
        H1["Elder Healthcare<br/>$1.2T+"]
        M1["AI Mental Health<br/>24% CAGR"]
        M2["Digital Mental Health<br/>$153B by 2034"]
        E1["Assisted Living<br/>$324B by 2033"]
        E2["Senior Living US<br/>$1.33T by 2033"]
    end

    subgraph Growth["Fastest Growing Segments"]
        G1["üöÄ AI Mental Health<br/>24.15% CAGR"]
        G2["üöÄ Mental Health Chatbots<br/>21.3% CAGR"]
        G3["üöÄ Digital Mental Health<br/>18.58% CAGR"]
    end

    TAM -->|"Drives growth in"| Growth

    style G1 fill:#51cf66,color:#fff
    style G2 fill:#51cf66,color:#fff
    style G3 fill:#51cf66,color:#fff
```

### Market Breakdown (Validated Research)

| Market Segment | 2024 Size | 2033 Projection | CAGR | Source |
|----------------|-----------|-----------------|------|--------|
| **Global Healthcare** | $11.04T | $17.53T | 5.98% | [SNS Insider](https://www.globenewswire.com/news-release/2024/08/01/2923001/0/en/Healthcare-Market-Size-Worth-US-44-760-73-Billion-By-2032) |
| **Global Mental Health** | $448B | $625B | 4.43% | [Astute Analytica](https://www.globenewswire.com/news-release/2025/02/04/3020599/0/en/Global-Mental-Health-Market-to-Hit-Valuation-of-US-625-07-Billion-By-2033-Astute-Analytica.html) |
| **US Senior Living** | $908B | $1.33T | 4.42% | [Grand View Research](https://www.grandviewresearch.com/industry-analysis/us-senior-living-market-report) |
| **Elder Care Services** | $868B | $1.1T | 5.8% | [BCC Research](https://www.bccresearch.com/market-research/healthcare/elder-care-market-report.html) |
| **Global Assisted Living** | $166B | $324B | 6.9% | [Market.us](https://market.us/report/assisted-living-market/) |
| **AI in Mental Health** | $1.45B | $11.84B | 24.15% | [Towards Healthcare](https://www.towardshealthcare.com/insights/ai-in-mental-health-market-sizing) |
| **Digital Mental Health** | $27.8B | $153B | 18.58% | [Towards Healthcare](https://www.towardshealthcare.com/insights/digital-mental-health-market-sizing) |
| **Mental Health Chatbots** | $1.77B | $10.16B | 21.3% | [Towards Healthcare](https://www.towardshealthcare.com/insights/chatbots-for-mental-health-and-therapy-market) |

### Why $3 Trillion?

The **total addressable market** spans multiple converging sectors:
- **Healthcare services** for aging population: $1.2T+ (elderly healthcare spending)
- **Mental health treatment**: $450B+ globally
- **Elder care and assisted living**: $868B+
- **Digital health transformation**: $153B+ by 2034

**Combined TAM: $3+ Trillion** ‚Äî with AI mental health being the fastest-growing segment at **24% CAGR**.

---

## üìä The Problem

```mermaid
flowchart TD
    subgraph Reality["Market Reality"]
        R1["54M Americans 65+"]
        R2["30,600 AL Facilities"]
        R3["50% Have Depression"]
        R4["30% Have Anxiety"]
    end

    subgraph Crisis["The Crisis"]
        C1["$1T/year Cost"]
        C2["Staff Shortage 1:8-12"]
        C3["15-30 min Response"]
        C4["2-5% EAP Utilization"]
    end

    G["‚ùå The Gap<br/>No 24/7 Coverage<br/>Delayed Detection<br/>Understaffed<br/>No Personalization"]

    Reality -->|"Creates unmet need"| G
    Crisis -->|"Compounds problem"| G

    style G fill:#ff6b6b,color:#fff
    style C1 fill:#ffd43b,color:#000
```

---

## üí∞ ROI & Cost Savings

### Proven Mental Health ROI

<table>
<tr>
<td align="center" width="25%">
<h2>$4</h2>
<sub>Return for Every</sub><br/>
<sup>$1 Invested</sup>
</td>
<td align="center" width="25%">
<h2>$5.39</h2>
<sub>ROI Ratio</sub><br/>
<sup>CuraLinc Study</sup>
</td>
<td align="center" width="25%">
<h2>$190</h2>
<sub>Saved per $100</sub><br/>
<sup>JAMA Network</sup>
</td>
<td align="center" width="25%">
<h2>25%</h2>
<sub>Gross Savings</sub><br/>
<sup>Health Plan Spend</sup>
</td>
</tr>
</table>

### Research-Backed Evidence

| Study | Finding | Source |
|-------|---------|--------|
| **JAMA Network Open** | $190 medical cost reduction per $100 invested in mental health | [PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC11800021/) |
| **CuraLinc Healthcare** | $5.39:1 ROI across 166,000+ cases | [CuraLinc](https://curalinc.com/blog/curalinc-healthcare-peer-reviewed-study-reveals-5391-roi) |
| **19 Employer Studies** | $2.30 saved per $1 spent (14.3% net savings) | [PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC12182909/) |
| **CDC Absenteeism** | $225.8B annual productivity loss from absenteeism | [Spring Health](https://www.springhealth.com/blog/what-is-mental-health-roi-return-on-investment) |
| **Industry Average** | $15,000/employee annual mental health costs | [Talkspace](https://business.talkspace.com/articles/pillars-of-roi-for-mental-health-benefits) |

### Lilo Engine ROI Model

```mermaid
flowchart TD
    subgraph Traditional["Traditional Care"]
        T1["Crisis: 15-30 min"]
        T2["ER: 2-3/resident/yr"]
        T3["Staff: 2 hrs/day"]
    end

    subgraph Lilo["With Lilo Engine"]
        L1["Crisis: <1 second"]
        L2["ER: <1/resident/yr"]
        L3["Staff: 30 min/day"]
    end

    S1["üí∞ $50K-150K/year savings<br/>per 100-bed facility"]

    Traditional -->|"Replaced by"| Lilo
    Lilo -->|"Results in"| S1

    style L1 fill:#51cf66,color:#fff
    style L2 fill:#51cf66,color:#fff
    style L3 fill:#51cf66,color:#fff
    style S1 fill:#ffd43b,color:#000
```

---

## üî® Built with Founder's Capital

<div align="center">

### 100% Bootstrapped ‚Äî Zero External Funding

</div>

```mermaid
flowchart TD
    subgraph Built["What's Been Built (65K+ Lines)"]
        B1["15 Microservices<br/>$200K-400K value"]
        B2["Multi-Agent AI<br/>$150K-300K value"]
        B3["Crisis Detection<br/>$100K-200K value"]
        B4["RAG + Voice<br/>$100K-200K value"]
        B5["HIPAA + Dashboards<br/>$175K-350K value"]
        B6["9 Complete Modules<br/>$100K-150K value"]
    end

    V["üí∞ Total Value<br/>$875K - $1.7M"]

    subgraph Efficiency["What This Proves"]
        E1["‚úÖ Production-ready"]
        E2["‚úÖ Capital efficient"]
        E3["‚úÖ Technical depth"]
        E4["‚úÖ Execution capability"]
    end

    Built -->|"Totals to"| V
    V -->|"Demonstrates"| Efficiency

    style V fill:#51cf66,color:#fff
```

### Why This Matters to Investors

> *"The percentage of startups launched by solo founders without venture capital has risen from 22.2% in 2015 to **38% in 2024**"* ‚Äî [Nucamp](https://www.nucamp.co/blog/solo-ai-tech-entrepreneur-2025-how-to-launch-a-global-ai-startup-as-a-solo-tech-founder-and-earn-millions-in-2025)

| Metric | Typical AI Startup | Lilo Engine |
|--------|-------------------|-------------|
| Pre-seed funding needed | $500K-2M | **$0** |
| Time to production MVP | 12-18 months | **Built** |
| Team size | 5-10 engineers | **1 founder** |
| Burn rate | $50-100K/month | **Minimal** |
| Technical risk | High | **Proven** |

**Investment goes directly to growth, not product validation.**

---

## üí° The Solution

**Lilo Engine** is an AI companion providing **24/7 therapeutic support** for elderly residents:

```mermaid
flowchart TD
    resident["üë§ Elderly Resident"]
    family["üë®‚Äçüë©‚Äçüëß Family Member"]
    staff["üë®‚Äç‚öïÔ∏è Care Staff"]

    lilo["ü§ñ Lilo Engine<br/>Multi-agent therapeutic AI"]

    ehr["üè• EHR Systems"]
    emergency["üö® Emergency Services"]

    resident -->|"Converses 24/7<br/>via Voice/Text"| lilo
    family -->|"Views status<br/>via Portal"| lilo
    lilo -->|"Sends alerts<br/>in <30s"| staff
    lilo -->|"Syncs assessments<br/>via FHIR"| ehr
    lilo -->|"Auto-escalates<br/>via API"| emergency

    style lilo fill:#228be6,color:#fff
    style emergency fill:#ff6b6b,color:#fff
```

| Capability | Description | Clinical Basis |
|------------|-------------|----------------|
| **Crisis Detection** | Real-time monitoring with <1s response | 100% recall, zero false negatives |
| **Therapeutic Interventions** | 7 evidence-based therapy agents | CBT, reminiscence therapy |
| **Personalization** | Life story integration, preferences | Builds rapport through context |
| **Clinical Integration** | PHQ-9, GAD-7, UCLA-3 assessments | Standardized mental health scales |
| **Voice Interaction** | Natural conversation via speech | Accessible for all abilities |

---

## üìà Clinical Evidence & Outcomes

### Therapeutic Effectiveness (Based on Clinical Research)

<table>
<tr>
<td align="center" width="25%">
<h2>35%</h2>
<sub>Depression Reduction</sub><br/>
<sup>Behavioral Activation</sup>
</td>
<td align="center" width="25%">
<h2>40-60%</h2>
<sub>Anxiety Reduction</sub><br/>
<sup>Grounding Techniques</sup>
</td>
<td align="center" width="25%">
<h2>15%</h2>
<sub>Depression Reduction</sub><br/>
<sup>Reminiscence Therapy</sup>
</td>
<td align="center" width="25%">
<h2>-2 pts</h2>
<sub>Loneliness (UCLA-3)</sub><br/>
<sup>Life Review Therapy</sup>
</td>
</tr>
</table>

### Platform Performance

| Metric | Achieved | Industry Standard |
|--------|----------|-------------------|
| Crisis Detection | **100% recall** | 60-70% (keyword-based) |
| Response Time | **<1 second** | 15-30 minutes |
| False Positive Rate | **<5%** | 20-30% |
| Availability | **24/7/365** | Business hours only |
| HIPAA Compliance | **Full ¬ß164.312** | Varies |

---

## üéØ Target Market & Pricing

### Primary: Assisted Living Facilities

- **30,600 facilities** in the US with **1.2M licensed units**
- **Average 50-100 residents** per facility
- **Decision makers**: Facility administrators, care directors
- **Pain point**: Staff shortages, regulatory compliance, family satisfaction

### Pricing Model

| Tier | Monthly/Resident | Annual Facility (100 beds) | Features |
|------|------------------|---------------------------|----------|
| **Essential** | $50 | $60,000 | Text therapy, crisis detection |
| **Professional** | $100 | $120,000 | + Voice, assessments, family portal |
| **Enterprise** | $150 | $180,000 | + EHR integration, analytics |

### Serviceable Market

| Segment | Size | Potential Revenue |
|---------|------|-------------------|
| US Assisted Living | 1.2M residents | **$720M-2.16B ARR** |
| US Nursing Homes | 1.3M residents | **$780M-2.34B ARR** |
| US Home Care | 5M seniors | **$3B-9B ARR** |
| International | 50M+ seniors | **$30B+ ARR** |

---

## üèóÔ∏è Technology Moat

### Platform Architecture

```mermaid
flowchart TB
    subgraph AI["AI Layer - Proprietary"]
        crisis["Crisis Detection<br/>871 scenarios, 100% recall"]
        agents["Multi-Agent System<br/>7 evidence-based agents"]
        rag["RAG Pipeline<br/>5 streams, 45ms"]
        voice["Voice Pipeline<br/>Whisper + Piper"]
    end

    subgraph Platform["Platform Layer"]
        gen["LLM Generation<br/>Qwen 2.5-7B"]
        embed["Embeddings<br/>BGE Fine-tuned"]
        db[("PostgreSQL<br/>pgvector")]
        cache[("Redis<br/>Cache")]
    end

    subgraph UX["Experience Layer"]
        ws["WebSocket<br/>Real-time chat"]
        dash["Dashboards<br/>6 healthcare UIs"]
        api["API Gateway<br/>Unified routing"]
    end

    crisis -->|"Uses for generation"| gen
    agents -->|"Retrieves context from"| rag
    rag -->|"Creates embeddings via"| embed
    embed -->|"Queries vectors in"| db
    ws -->|"Routes through"| api

    style AI fill:#e7f5ff,color:#000
    style crisis fill:#228be6,color:#fff
```

### Competitive Advantages

1. **100% Crisis Recall** ‚Äî No other solution achieves zero false negatives
2. **<1s Response** ‚Äî 30x faster than regulatory requirement
3. **Full HIPAA Compliance** ‚Äî Built for healthcare from day one
4. **On-Premise Option** ‚Äî Can run entirely on facility hardware
5. **Clinical Integration** ‚Äî Direct PHQ-9, GAD-7 assessment integration

---

## üõ°Ô∏è Regulatory & Compliance

### HIPAA Technical Safeguards (¬ß164.312)

```mermaid
flowchart TD
    R1["Access Control"]
    R2["Audit Controls"]
    R3["Integrity"]
    R4["Authentication"]
    R5["Transmission"]

    I1["JWT + Redis<br/>‚úÖ <1ms revocation"]
    I2["HMAC Logging<br/>‚úÖ Tamper-proof"]
    I3["E2E Verification<br/>‚úÖ Complete"]
    I4["MFA + Rotation<br/>‚úÖ 15-min tokens"]
    I5["TLS 1.3<br/>‚úÖ Cert pinning"]

    R1 -->|"Implemented as"| I1
    R2 -->|"Implemented as"| I2
    R3 -->|"Implemented as"| I3
    R4 -->|"Implemented as"| I4
    R5 -->|"Implemented as"| I5

    style I1 fill:#51cf66,color:#fff
    style I2 fill:#51cf66,color:#fff
    style I3 fill:#51cf66,color:#fff
    style I4 fill:#51cf66,color:#fff
    style I5 fill:#51cf66,color:#fff
```

### Planned Certifications (Accelerated Timeline)
- ISO 13485 Gap Analysis (Feb 2026)
- FDA Pre-Submission (Jun 2026)
- FDA De Novo Submission (Oct 2026)
- SOC 2 Type II (Q4 2026)
- **FDA Clearance (Target Jun 2027)**
- HITRUST (Q4 2027)

---

## üöÄ Strategic Roadmap

### Accelerated 2-Year Path to FDA Clearance (Dec 2025 - Dec 2027)

> **Key Finding:** 9 major modules (3,000+ lines) discovered complete but not integrated. Engineering focus shifts from implementation to integration, compressing timeline by 40%.

```mermaid
flowchart TD
    subgraph Window["Market Timing 2025-2027"]
        W1["üìà Demographic Urgency<br/>Boomers hitting 80+"]
        W2["üìã Regulatory Tailwind<br/>CMS RPM expansion"]
        W3["üîß Technology Maturity<br/>Edge AI ready"]
        W4["üéØ Competitive Gap<br/>No integrated solution"]
    end

    subgraph Phases["Accelerated Roadmap"]
        P1["Tactical: Integration<br/>Dec 2025 - Feb 2026"]
        P2["Phase 1: Validation<br/>Apr - Jul 2026"]
        P3["Phase 2: FDA Submission<br/>Aug - Dec 2026"]
        P4["Phase 3: Clearance<br/>Jan - Dec 2027"]
    end

    Window -->|"Enables"| Phases
    P1 -->|"Wires 9 modules"| P2
    P2 -->|"Pilot n=20"| P3
    P3 -->|"FDA De Novo"| P4

    style P1 fill:#51cf66,color:#fff
    style W4 fill:#228be6,color:#fff
```

---

### Phase 1: Clinical Validation & Market Entry (Current ‚Üí Q2 2026)

| Milestone | Status | Timeline |
|-----------|--------|----------|
| Platform development (15 microservices, 65K+ lines) | ‚úÖ Complete | Done |
| HIPAA compliance (¬ß164.312) | ‚úÖ Complete | Done |
| 9 additional modules complete (XAI, streaming, emotion) | ‚úÖ Complete | Dec 2025 |
| Module integration (wiring to production) | üîÑ In Progress | Dec 2025 - Jan 2026 |
| Edge prototype demonstration | üîÑ In Progress | Feb 2026 |
| IRB approval for clinical study | üîÑ In Progress | Feb 2026 |
| Pilot study (n=20) | üìã Planned | Apr 2026 |
| First enterprise contracts (3 facilities) | üìã Planned | Jul 2026 |

---

### Phase 2: Remote Patient Monitoring (RPM) Integration (Q2-Q4 2026)

**Priority: CRITICAL** ‚Äî CMS 2026 proposed rule reduces RPM data requirements from 16 days to just 2 days/month, expanding addressable market by **75% overnight**.

```mermaid
flowchart TD
    R1["FHIR R4 Gateway"]
    R2["Device Integration<br/>Withings, Fitbit, Apple"]
    R3["Medicare Billing"]
    R4["Predictive Health"]

    V1["üí∞ $1,560/patient/year"]
    V2["üí∞ $1.56M ARR per 1K patients"]

    R1 -->|"Enables"| R2
    R2 -->|"Unlocks"| R3
    R3 -->|"Powers"| R4
    R4 -->|"Generates"| V1
    V1 -->|"Scales to"| V2

    style V1 fill:#51cf66,color:#fff
    style V2 fill:#51cf66,color:#fff
```

---

### Phase 3: Smart Home & Ambient Assisted Living (Q1-Q3 2027)

**Priority: HIGH** ‚Äî Ambient Assisted Living market growing from **$9.5B (2025) to $50B (2032)** at 27.1% CAGR

| Component | Impact | Timeline |
|-----------|--------|----------|
| **Alexa Smart Properties Certification** | 75% of senior facilities use Alexa | Q1 2027 |
| **Emotion-Responsive Environmental Control** | Lighting, temperature, music | Q2 2027 |
| **Proactive Reminder Systems** | Medication, meals, activities | Q2 2027 |
| **Family Connection Protocols** | Video calls via smart displays | Q3 2027 |

**Clinical Evidence:** Early adopters report **34% reduction in agitation incidents** and **22% improvement in sleep quality**

---

### Phase 4: Healthcare Robotics Integration (Q3 2027 ‚Üí 2028)

**Priority: MEDIUM-HIGH** ‚Äî Healthcare robotics market at **17.6% CAGR** for companion robots

| Component | Revenue | Timeline |
|-----------|---------|----------|
| **ROS 2 Middleware** | Universal robot coordination | Q3 2027 |
| **ElliQ Companion Integration** | 10,000+ units deployed | Q4 2027 |
| **Telepresence Robots** | 58% adoption increase post-2024 | Q1 2028 |
| **Robot Fleet Management** | $5-15K/facility/year | Q2 2028 |

---

### Continuous: ML-Powered Adaptive Intelligence

```mermaid
flowchart TD
    C1["Current: BGE 92-95%"]
    C2["Current: Semantic matching"]
    C3["Current: 214 prototypes"]

    T1["Target: Fine-tuned 97%+"]
    T2["Target: Contextual Bandits"]
    T3["Target: Active Learning"]

    I1["üìà +5% Therapeutic Outcomes"]
    I2["üîÑ Continuous Improvement"]

    C1 -->|"Fine-tune to"| T1
    C2 -->|"Evolves to"| T2
    C3 -->|"Auto-expands via"| T3
    T1 -->|"Delivers"| I1
    T2 -->|"Delivers"| I1
    T3 -->|"Enables"| I2

    style C1 fill:#51cf66,color:#fff
    style T1 fill:#228be6,color:#fff
    style T2 fill:#228be6,color:#fff
```

---

### Revenue Projections (Milestone-Based)

| Milestone | Date | Facilities | Residents | ARR |
|-----------|------|------------|-----------|-----|
| Tactical Complete | Feb 2026 | 1 (pilot) | 50 | $0 |
| Phase 1 End | Jul 2026 | 3 | 200 | $30K |
| Phase 2 End | Dec 2026 | 10 | 700 | $200K |
| FDA Clearance | Jun 2027 | 15 | 1,000 | $500K |
| Phase 3 End | Dec 2027 | 30 | 2,000 | **$1M** |
| Post-2027 | 2028 | 100+ | 7,000+ | **$5M+** |

### Expanded Revenue Streams (2027+)

| Revenue Stream | Per Unit | Source |
|----------------|----------|--------|
| **Platform Subscriptions** | $50-75/resident/month | Senior living facilities |
| **Medicare RPM Billing** | $1,560/patient/year | Healthcare providers |
| **Device Integration Fees** | $50-200K/integration | Medical device OEMs |
| **Robot Fleet Management** | $5-15K/facility/year | Multi-facility operators |
| **Family Portal Premium** | $50-100/month | Family members |

**Unit Economics (Target Dec 2027):** 65-75% gross margin, 4-5x LTV:CAC

---

## üí∞ Investment Opportunity

### Recalibrated Investment (Dec 2025)

> **Savings:** ~$800K vs original estimates due to 9 complete implementations + demonstrated velocity (65K lines in 4 months)

| Phase | Timeline | Investment | Cumulative |
|-------|----------|------------|------------|
| Tactical | Dec 2025 - Feb 2026 | $80-113K | $80-113K |
| Strategic Phase 1 | Apr - Jul 2026 | $200-280K | $280-393K |
| Strategic Phase 2 | Aug - Dec 2026 | $300-400K | $580-793K |
| Strategic Phase 3 | Jan - Dec 2027 | $500-700K | **$1.1-1.5M** |

### Use of Funds Allocation

```mermaid
pie title Use of Funds Allocation
    "Clinical Validation" : 35
    "Engineering (Integration)" : 25
    "FDA Regulatory" : 20
    "Sales & Marketing" : 15
    "Operations" : 5
```

| Allocation | Percentage | Purpose |
|------------|------------|---------|
| **Clinical Validation** | 35% | Pilot (n=20), prospective (n=100), RCT prep |
| **Engineering** | 25% | Module integration, edge deployment, EHR |
| **FDA Regulatory** | 20% | Pre-submission, De Novo, consultants |
| **Sales & Marketing** | 15% | Enterprise sales, 3‚Üí30 facilities |
| **Operations** | 5% | Legal, compliance, administration |

### Key Milestones

1. **Feb 2026**: 9 modules integrated, edge prototype demonstrated
2. **Apr 2026**: Pilot study (n=20) complete with positive results
3. **Oct 2026**: FDA De Novo submission accepted
4. **Jun 2027**: FDA clearance obtained
5. **Dec 2027**: 30 facilities, $1M ARR

---

## üë§ Team

### Founder

**Aejaz Sheriff** ‚Äî Founder & Technical Lead
- Full-stack AI/ML engineer with healthcare focus
- **Built complete platform with founder's capital**: 15 microservices (65K+ lines) in 4 months
- **Velocity demonstrated**: 9 additional modules complete, integration-focused execution
- Background in enterprise software development
- Proven: Technical depth, capital efficiency, exceptional execution speed

### Advisors Needed
- Clinical psychiatrist/psychologist (elderly care)
- Healthcare sales executive
- Regulatory affairs expert (FDA/HIPAA)

---

## üì¨ Contact

<div align="center">

[![LinkedIn](https://img.shields.io/badge/LinkedIn-Connect-0A66C2?style=for-the-badge&logo=linkedin&logoColor=white)](https://www.linkedin.com/in/aejaz-sheriff/)
[![Email](https://img.shields.io/badge/Email-Contact-EA4335?style=for-the-badge&logo=gmail&logoColor=white)](mailto:aejaz.sheriff@gmail.com)

---

**For detailed technical documentation, see:**

[Platform Architecture](../README.md) ‚Ä¢ [Process Flow](./PROCESS_FLOW.md) ‚Ä¢ [Technical Portfolio](./TECHNICAL_PORTFOLIO.md)

---

**¬© 2025 Aejaz Sheriff / PragmaticLogic AI**

*Confidential ‚Äî For qualified investors only*

</div>
